CCMG
BMY.RT

Clark Capital Management Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Clark Capital Management Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,735
Closed -$9K – 376
2020
Q4 		$9K Hold
13,735
– – ﹤0.01% 340
2020
Q3 		$31K Hold
13,735
– – ﹤0.01% 308
2020
Q2 		$49K Sell
13,735
-7
-0.1% -$25 ﹤0.01% 297
2020
Q1 		$52K Buy
13,742
+293
+2% +$965 ﹤0.01% 276
2019
Q4 		$40K Buy
+13,449
New +$35K ﹤0.01% 309

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Clark Capital Management Group's BMY.RT Position: Q1 2021 in Review

Clark Capital Management Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 13,735 shares — an estimated $9K sold.

Clark Capital Management Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $52K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Clark Capital Management Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Clark Capital Management Group sold 13,735 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9K.
  • Clark Capital Management Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Clark Capital Management Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $52K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Clark Capital Management Group's 13F filing for Q1 2021, filed 17 May 2021.